Agilent to Debut Automated Liquid-Handling Workflow in Fall, High-Density Expression Chips in 2010 | GenomeWeb

By Justin Petrone

Continuing to invest in a business that is at the "center of its strategic emphasis," Agilent Technologies plans to launch a number of new array-related products in the coming months.

Agilent will launch an automated liquid-handling workflow by early October, and will add million-feature arrays in its high-density G3 format for expression profiling and location analysis studies within the next six to nine months, according to the firm's array team.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.